Assembly Biosciences, Inc. (ASMB)

NASDAQ: ASMB · Real-Time Price · USD

36.60

+0.47 (1.30%)

At close: Sep 4, 2026, 4:00 PM EDT

36.78

+0.18 (0.49%)

After-hours: Sep 4, 2026, 7:30 PM EDT

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.29	58.45	38.34	19.84	52.42	45.63
Short-Term Investments	288.08	189.66	73.74	110.41	39.19	101
Cash & Short-Term Investments	320.36	248.11	112.08	130.25	91.61	146.63
Cash Growth	327.26%	121.37%	-13.95%	42.18%	-37.52%	-32.25%
Accounts Receivable	0.82	0.97	-	0.04	0.94	0.34
Other Receivables	2.1	1.5	0.4	0.3	0.3	-
Receivables	2.92	2.47	0.4	0.34	1.24	0.34
Prepaid Expenses	4.7	3.97	3.02	3.2	4.11	7.24
Total Current Assets	327.98	254.55	115.5	133.79	96.97	154.2
Property, Plant & Equipment	2.54	2.73	3.35	2.72	3.94	7.18
Long-Term Investments	-	-	-	-	-	27.97
Long-Term Deferred Charges	-	-	-	-	0.2	0.2
Other Long-Term Assets	0.31	0.31	0.31	0.31	0.69	1.5
Total Assets	330.83	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.18	1.17	0.59	0.46	2.49	2.66
Accrued Expenses	5.35	10.14	9.14	6.63	9.84	10.26
Current Portion of Leases	0.61	0.57	0.46	1.22	3.36	3.15
Current Unearned Revenue	16.3	36.9	37.62	30.92	-	-
Other Current Liabilities	-	-	-	-	0.6	-
Total Current Liabilities	23.45	48.78	47.8	39.23	16.3	16.07
Long-Term Leases	1.74	2.06	2.63	1.12	0.1	3.33
Long-Term Unearned Revenue	-	-	35.38	55.38	2.73	2.73
Total Liabilities	25.18	50.84	85.81	95.73	19.13	22.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.01	0.01	0	0.05
Additional Paid-In Capital	1,151	1,039	859.49	826.92	807.98	800.73
Retained Earnings	-844.98	-832.05	-825.93	-785.75	-724.52	-631.43
Comprehensive Income & Other	-0.62	-0.04	-0.21	-0.08	-0.8	-0.42
Shareholders' Equity	305.65	206.75	33.36	41.1	82.66	168.93
Total Liabilities & Equity	330.83	257.59	119.17	136.82	101.79	191.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.35	2.63	3.09	2.34	3.47	6.48
Net Cash (Debt)	318.01	245.48	108.99	127.91	88.15	168.12
Net Cash Growth	341.09%	125.23%	-14.79%	45.11%	-47.57%	-18.50%
Net Cash Per Share	19.44	21.90	18.15	27.94	21.85	46.61
Filing Date Shares Outstanding	20.36	15.86	7.5	5.48	4.33	4.01
Total Common Shares Outstanding	19.85	15.86	7.46	5.48	4.07	4.01
Working Capital	304.53	205.77	67.7	94.56	80.67	138.13
Book Value Per Share	15.40	13.04	4.47	7.50	20.29	42.13
Tangible Book Value	305.65	206.75	33.36	41.1	82.66	168.93
Tangible Book Value Per Share	15.40	13.04	4.47	7.50	20.29	42.13
Machinery	-	-	-	-	0.8	0.72
Leasehold Improvements	-	-	-	-	1.63	1.63

SEC Filings: 10-K · 10-Q